In these groups comprised of morbidly obese female patients, known clinical indicators of NAFLD (e.g., insulin, triglycerides, alanine aminotransferase, aspartate aminotransferase) changed significantly between the groups. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.